José Oberholzer
Oprichter bij SIGILON THERAPEUTICS, INC.
Profiel
José Oberholzer is the founder of Sigilon Therapeutics, Inc. He is currently the Director at Charles O Strickler Transplant Center since 2017.
Previously, he worked as a Professor at the University of Illinois and as the Head-Islet Transplant Program at the University of Geneva from 1998 to 2002.
Dr. Oberholzer has a graduate degree from Harvard University and an undergraduate degree from the University of Zurich Medical School.
Actieve functies van José Oberholzer
| Bedrijven | Functie | Begin |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Oprichter | 14-05-2015 |
| Charles O Strickler Transplant Center | Directeur/Bestuurslid | 01-03-2017 |
Celltrans, Inc.
 Celltrans, Inc. Miscellaneous Commercial ServicesCommercial Services Celltrans, Inc. develops, manufactures, and commercializes cellular therapies and bioengineered technologies for the therapeutic treatment of diabetes and other endocrine disorders. The private company is based in Chicago, IL. The company was founded by José Oberholzer. | Oprichter | - |
Eerdere bekende functies van José Oberholzer
| Bedrijven | Functie | Einde |
|---|---|---|
| University of Geneva | Corporate Officer/Principal | 01-01-2002 |
| University of Illinois | Corporate Officer/Principal | - |
Opleiding van José Oberholzer
| University of Zurich Medical School | Undergraduate Degree |
| Harvard University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Charles O Strickler Transplant Center | |
Celltrans, Inc.
Celltrans, Inc. Miscellaneous Commercial ServicesCommercial Services Celltrans, Inc. develops, manufactures, and commercializes cellular therapies and bioengineered technologies for the therapeutic treatment of diabetes and other endocrine disorders. The private company is based in Chicago, IL. The company was founded by José Oberholzer. | Commercial Services |
